President Trump has signed a new EO that attempts to bring US drug prices in line with those that other countries pay for the same drugs. The methods proposed for reducing drug prices, however, may not be allowed under current rules and regs. HHS and the FTC will be involved in trying to determine whether and how this could work. Drug companies oppose the order saying it will impede research and development of new drugs.
https://www.reuters.com/business/healthcare-pharmaceuticals/trump-says-he-will-cut-drug-prices-by-59-2025-05-12/
Meantime, tariffs against Chinese goods have dropped to 30 percent, from 145 percent, for the next 90 days. Hoping this is good news and keeps open supplies of meds like generic hydroxyurea that originates in China.